GSK plc GSK
NYSE GSK
$50.67 +0.26 (+0.52%)
As of: Nov 6, 2026 · 1:26 PM EST

Gsk (GSK) Beginning Cash Balance (2025 - 2026)

Updated

Analysis

Gsk (GSK) Beginning Cash Balance (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,220.49 Bn 1,194.11 Bn 20.46 Bn
2 Johnson & Johnson 663.01 Bn 582.87 Bn 17.30 Bn
3 AbbVie 515.26 Bn 483.27 Bn 13.12 Bn
4 Merck 363.15 Bn 326.10 Bn 13.19 Bn
5 Novartis Ag 315.67 Bn 288.91 Bn -
6 Astrazeneca 289.75 Bn 263.64 Bn 13.26 Bn
7 Amgen 249.57 Bn 201.23 Bn 7.58 Bn
8 Gilead Sciences 208.99 Bn 184.10 Bn 6.73 Bn
9 Pfizer 167.01 Bn 114.37 Bn 12.56 Bn
10 Gsk 102.59 Bn 85.43 Bn 8.73 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 4.37 Bn
Mar 31, 2026 4.38 Bn
Dec 31, 2025 4.53 Bn
Sep 30, 2025 4.59 Bn
Mar 31, 2025 4.29 Bn
API Access

Gsk Beginning Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=beginning-cash-balance&ticker=GSK&period=max&api_key=YOUR_API_KEY